导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.39% | 628/1050 |
| 近一周 | -0.72% | 88/1104 |
| 近一月 | 3.72% | 9/1102 |
| 近一季 | 2.25% | 170/1092 |
| 近半年 | 0.79% | 405/1070 |
| 近一年 | 0.27% | 573/1018 |
| 近两年 | 37.89% | 609/926 |
| 近三年 | 22.19% | 471/834 |
| 成立以来 | 27.37% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.63% 888/1070 |
-4.15% 774/1101 |
- - |
- - |
| 2025 | 12.96% 786/1065 |
-0.33% 813/1014 |
10.15% 98/1038 |
-1.68% 1016/1050 |
4.65% 147/1065 |
| 2024 | 28.95% 26/1011 |
3.89% 135/960 |
4.01% 134/983 |
17.46% 117/991 |
1.61% 250/1011 |
| 2023 | -22.13% 730/952 |
-7.87% 837/880 |
-6.02% 579/895 |
0.30% 77/915 |
-10.34% 868/952 |
| 2022 | -16.50% 207/867 |
-4.24% 26/773 |
3.46% 610/806 |
-20.14% 757/845 |
5.53% 179/867 |
| 2021 | -2.40% 386/740 |
6.73% 35/580 |
-3.40% 572/659 |
-5.31% 368/704 |
-0.02% 440/740 |
| 2020 | 8.26% 400/554 |
-13.28% 398/419 |
4.10% 417/466 |
12.95% 181/517 |
6.18% 416/554 |
| 2019 | 39.68% 223/410 |
24.36% 754/1146 |
1.03% 233/1228 |
1.05% 306/390 |
10.02% 159/410 |
| 2018 | - - |
- - |
-1.48% 102/990 |
6.97% 39/1000 |
-9.49% 258/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 嘉实金融精选股票A VS. 东吴新产业精选股票A(580008) |